A Study to Investigate the Safety of GSK4024484 in Healthy Adult Participants

Clinical trial NCT06171113 · COMPLETED

Trial details

NCT number: NCT06171113
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Malaria, Falciparum

Start date: 2023-12-11
Primary completion: 2026-06-16
Enrollment: 123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.